Search Result "CRL/SCF E3 ligase"
SCF E3 Ubiquitin Ligases as Anticancer Targets
Journal: Current Cancer Drug Targets
Volume: 11 Issue: 3 Year: 2011 Page: 347-356
Author(s): L. Jia, Y. Sun
The SCF-type E3 Ubiquitin Ligases as Cancer Targets
Journal: Current Cancer Drug Targets
Volume: 16 Issue: 2 Year: 2016 Page: 119-129
Author(s): Kyoko Kitagawa,Masatoshi Kitagawa
RING Finger E3 Ubiquitin Ligases: Structure and Drug Discovery
Journal: Current Pharmaceutical Design
Volume: 15 Issue: 3 Year: 2009 Page: 3716-3731
Author(s): Christos T. Chasapis, Georgios A. Spyroulias
Cullin-RING Ligases as Attractive Anti-cancer Targets
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 1 Year: 2013 Page: 3215-3225
Author(s): Yongchao Zhao, Yi Sun
Negative Regulation of NEDD8 Conjugation Pathway by Novel Molecules and Agents for Anticancer Therapy
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 2 Year: 2013 Page: 4131-4139
Author(s): Tomoaki Tanaka, Tatsuya Nakatani, Tetsu Kamitani
Ring Finger Ubiquitin Protein Ligases and Their Implication to the Pathogenesis of Human Diseases
Journal: Current Pharmaceutical Design
Volume: 15 Issue: 3 Year: 2009 Page: 3697-3715
Author(s): Helen C. Ardley
Pharmaceutical Perspectives of HECT-TYPE Ubiquitin Ligase Smurf1
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 1 Year: 2013 Page: 3226-3233
Author(s): Yu Cao, Lingqiang Zhang
Targeting the Ubiquitin-Mediated Proteasome Degradation of p53 for Cancer Therapy
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 1 Year: 2013 Page: 3248-3262
Author(s): Tiffany DeVine, Mu-Shui Dai
Cdc20: A Potential Novel Therapeutic Target for Cancer Treatment
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 1 Year: 2013 Page: 3210-3214
Author(s): Zhiwei Wang, Lixin Wan, Jiateng Zhong, Hiroyuki Inuzuka, Pengda Liu, Fazlul H. Sarkar, Wenyi Wei
Disruption of the Keap1-Containing Ubiquitination Complex as an Antioxidant Therapy
Journal: Current Topics in Medicinal Chemistry
Volume: 7 Issue: 1 Year: 2007 Page: 972-978
Author(s): Jonathan T. Kern, Mark Hannink, J. Fred Hess